Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation
View abstract on PubMed
Summary
This summary is machine-generated.Kaposi's sarcoma herpesvirus (KSHV) latency-associated nuclear antigen (LANA) upregulates Aurora A kinase, promoting p53 degradation. Inhibiting Aurora A kinase restores p53 activity, offering a potential therapeutic strategy for KSHV-associated cancers.
Area Of Science
- Oncology
- Virology
- Molecular Biology
Background
- Aberrant Aurora A kinase expression is linked to cancer development and chromosome instability.
- Kaposi's sarcoma herpesvirus (KSHV) latency-associated nuclear antigen (LANA) targets the tumor suppressor p53 for degradation via the EC(5)S ubiquitin complex.
- LANA utilizes its SOCS-box motif to recruit the EC(5)S ubiquitin complex for p53 degradation.
Purpose Of The Study
- To investigate the role of Aurora A kinase in KSHV-associated tumorigenesis.
- To elucidate the mechanism by which LANA influences Aurora A kinase expression and p53 stability.
- To explore the therapeutic potential of targeting the LANA-Aurora A-p53 axis.
Main Methods
- Quantitative analysis of Aurora A kinase expression in KSHV-infected cells and Kaposi's sarcoma tissues.
- Western blot analysis to assess p53 ubiquitylation and degradation.
- RNA interference (siRNA) and dominant-negative mutants to inhibit Aurora A kinase activity.
- Co-immunoprecipitation assays to study protein-protein interactions.
Main Results
- LANA upregulates Aurora A kinase transcription, leading to elevated levels in KSHV-infected cells and Kaposi's sarcoma.
- Aurora A kinase enhances the binding of p53 to LANA and facilitates LANA(SOCS)-mediated p53 ubiquitylation and degradation, requiring phosphorylation at Ser215 and Ser315.
- Inhibition of Aurora A kinase by shRNA or dominant-negative mutants disrupts LANA-induced p53 degradation, restoring p53's transcriptional and apoptotic functions.
Conclusions
- LANA upregulates Aurora A kinase, a cellular oncogene, contributing to KSHV-associated cancers.
- Aurora A kinase plays a critical role in LANA-mediated destabilization of the p53 tumor suppressor.
- Targeting Aurora A kinase presents a promising strategy for treating KSHV-associated malignancies.